Nationwide Children's Hospital Toledo, LLC
Nationwide Children's Hospital Toledo, LLC was paid $12.53M by Medicaid between May 2022 and Dec 2024, across 152 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 33% of everything it billed.
TOLEDO, OH 43608
Next to other Children's Hospital providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 14,307 | $647K | |
| 2023 | 80,010 | $6.42M | |
| 2024incomplete | 79,666 | $5.46M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 33% | 37,041 | 29,015 | $4.11M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 9.9% | 17,579 | 5,730 | $1.25M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 9.5% | 5,152 | 3,684 | $1.19M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7.3% | 12,262 | 4,071 | $920K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 5.4% | 486 | 280 | $673K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 3.5% | 450 | 279 | $444K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 4,520 | 1,849 | $349K |
| G0378 | Hospital observation service, per hour | 2.7% | 3,162 | 1,094 | $345K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.6% | 4,401 | 3,543 | $332K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.0% | 3,034 | 2,644 | $249K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 792 | 324 | $242K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.9% | 3,128 | 2,527 | $238K |
140 more codes
| 95812 | 1.5% | 199 | $188K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.3% | 620 | $169K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 1,714 | $146K |
| 97535 | Self-care/home management training, each 15 minutes | 1.1% | 2,871 | $138K |
| 92587 | <1% | 2,009 | $125K | |
| 95714 | <1% | 91 | $87K | |
| 94010 | <1% | 1,509 | $87K | |
| 93325 | <1% | 1,022 | $85K | |
| 95816 | <1% | 401 | $73K | |
| 93304 | <1% | 290 | $72K | |
| 96127 | <1% | 874 | $70K | |
| 96161 | <1% | 512 | $63K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 292 | $61K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 100 | $56K |
| 97116 | <1% | 1,218 | $46K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 366 | $42K |
| 92567 | <1% | 1,040 | $32K | |
| 99381 | <1% | 391 | $27K | |
| 42830 | <1% | 44 | $25K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 925 | $24K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 189 | $23K |
| 99383 | <1% | 289 | $23K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 188 | $20K |
| G0008 | Administration of influenza virus vaccine | <1% | 2,036 | $20K |
| 97162 | <1% | 232 | $20K | |
| 92579 | <1% | 341 | $18K | |
| 90670 | <1% | 1,984 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,547 | $17K |
| 92557 | <1% | 269 | $17K | |
| 31575 | <1% | 133 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,069 | $15K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 66 | $14K |
| 90633 | <1% | 2,287 | $14K | |
| 97165 | <1% | 128 | $14K | |
| 95700 | <1% | 90 | $13K | |
| 99384 | <1% | 160 | $13K | |
| 92523 | <1% | 151 | $13K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 2,007 | $12K |
| 90698 | <1% | 1,821 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 114 | $10K |
| 97802 | <1% | 118 | $10K | |
| 97166 | <1% | 89 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 39 | $9K |
| 94664 | <1% | 355 | $9K | |
| 90686 | <1% | 1,860 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 68 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 637 | $8K |
| 90697 | <1% | 1,282 | $8K | |
| 92609 | <1% | 102 | $8K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 754 | $7K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 187 | $7K |
| 93320 | <1% | 612 | $7K | |
| 90651 | <1% | 1,284 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,259 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 116 | $6K |
| 95711 | <1% | 76 | $6K | |
| 90680 | <1% | 2,043 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 367 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 42 | $6K |
| 90716 | <1% | 904 | $6K | |
| 29065 | <1% | 51 | $5K | |
| 90677 | <1% | 1,811 | $5K | |
| 90696 | <1% | 980 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,950 | $5K |
| J3590 | Unclassified biologics | <1% | 70 | $5K |
| 90710 | <1% | 1,171 | $4K | |
| 69210 | <1% | 334 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 54 | $4K |
| 90734 | <1% | 1,189 | $4K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 313 | $4K |
| 90620 | <1% | 490 | $4K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,338 | $3K |
| 90707 | <1% | 889 | $3K | |
| 90744 | <1% | 609 | $3K | |
| 29075 | <1% | 25 | $3K | |
| 90700 | <1% | 732 | $3K | |
| G0010 | Administration of hepatitis b vaccine | <1% | 242 | $3K |
| 93321 | <1% | 120 | $3K | |
| J3490 | Unclassified drugs | <1% | 92 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 418 | $2K |
| 90715 | <1% | 626 | $2K | |
| 90656 | <1% | 512 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 718 | $2K |
| 90648 | <1% | 392 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 379 | $2K |
| 92652 | <1% | 12 | $2K | |
| 97167 | <1% | 13 | $2K | |
| 73110 | <1% | 65 | $2K | |
| 99382 | <1% | 46 | $2K | |
| 90661 | <1% | 206 | $1K | |
| 97750 | <1% | 19 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 159 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 747 | $1K |
| 81003 | <1% | 806 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,842 | $942.14 |
| 90674 | <1% | 125 | $927.14 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 303 | $871.03 |
| 81001 | <1% | 357 | $639.18 | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 36 | $630.64 |
| 96376 | <1% | 304 | $599.64 | |
| 90381 | <1% | 96 | $534.24 | |
| 87428 | <1% | 53 | $503.05 | |
| 97161 | <1% | 15 | $438.20 | |
| 90380 | <1% | 87 | $397.43 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 631 | $317.81 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,790 | $265.59 |
| 94760 | <1% | 1,184 | $261.59 | |
| 73080 | <1% | 15 | $257.12 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 25 | $245.52 |
| 00126 | <1% | 97 | $183.43 | |
| 85027 | <1% | 47 | $182.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,299 | $176.19 |
| 90681 | <1% | 32 | $157.08 | |
| 81025 | <1% | 150 | $140.58 | |
| 92552 | <1% | 13 | $135.01 | |
| 85018 | <1% | 404 | $125.38 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,601 | $119.90 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 259 | $117.51 |
| 90480 | <1% | 137 | $83.88 | |
| 92582 | <1% | 24 | $80.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 310 | $55.99 |
| 81002 | <1% | 200 | $54.03 | |
| 90658 | <1% | 15 | $36.85 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 34 | $34.60 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 25 | $22.31 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 28 | $13.69 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 68 | $10.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 228 | $7.23 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 24 | $2.76 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 63 | $2.70 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 44 | $1.36 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 256 | $0.21 |
| 91321 | <1% | 38 | $0.05 | |
| 94761 | 0% | 119 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 98 | $0.00 |
| 92551 | 0% | 13 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 15 | $0.00 |
| 00731 | 0% | 53 | $0.00 | |
| 92504 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.